Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative treatments for lateral epicondylitis
NCT01897259Phase 2Unknown
- Sponsor
- Christine M. Kleinert Institute for Hand and Microsurgery
- Start
- Mar 2012
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide, dextrose, sodium morrhuate, diclofenac in Lateral Epicondylitis (LET), sponsored by Christine M. Kleinert Institute for Hand and Microsurgery. Status: unknown.
02
Drugs
triamcinolone acetonidedextrosesodium morrhuatediclofenac
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT01897259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897259.